Skip To Main Content
Keng Po Lai on Muck Rack

Keng Po Lai

As seen in: ACS Publications, Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Keng Po

Contact Keng Po, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Beyond a Barrier: Placental PFAS Transfer and Early-Life Metabolic Programming Click to copy article link Article link copied!

|
By Yajie Chu, Keng Po Lai
| dx.doi.org
Per- and polyfluoroalkyl substances (PFAS) are well-known to reach the fetus during pregnancy. (1) Fetal exposure is commonly estimated using a simple comparison between maternal serum and cord blood concentrations. (2) This approach implicitly treats the placenta as a passive conduit linking two biological compartments. Increasing evidence suggests that this view is incomplete.
Open in Who Shared Issue with article?

Impact of PFOS Exposure on Murine Fetal Hematopoietic Stem Cells, Associated with Intrauterine Metabolic Perturbation

|
By Wang Lee, Zheyu Cheng, Keng Po Lai, Jianing Wang
| dx.doi.org
Introduction Click to copy section linkSection link copied! Exposure to environmental pollution accounted for over 16% of deaths worldwide and is the second leading cause of noncommunicable diseases. (1,2) The disease risk associated with environmental pollution has risen by over 66% since 2000.
Open in Who Shared Issue with article?

Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for treating bladder cancer

|
By Keng Po Lai, Jian Chen
| Royal Society of Chemistry Verified
Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for treating bladder cancer Huanhuan Zhou, Ping Wang, Xian Qin, Xing Zhang, Keng Po Lai and Jian Chen Abstract Bladder cancer is one of the common cancers worldwide, leading to 213,000 deaths in 2020. Patient with progression of non-muscle invasive bladder cancer to muscle-invasive disease will have poorer prognosis and survival rate.
Open in Who Shared Issue with article?
See all 5 articles